Relmada Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | — | — | $21.9K |
| FY2012 | $3.7M | $18.4K | $1.8M |
| FY2013 | $21.6M | $20.0K | $3.5M |
| FY2014 | $26.9M | $25.8M | $25.6M |
| FY2015 | $15.6M | $24.4M | $22.5M |
| FY2016 | $3.2M | $10.2M | $8.5M |
| FY2017 | $1.4M | $2.8M | $1.7M |
| FY2018 | $8.6M | $3.0M | $2.2M |
| FY2019 | $2.6M | $10.2M | $9.2M |
| FY2020 | $12.6M | $118.2M | $2.5M |
| FY2021 | $15.1M | $223.3M | $44.4M |
| FY2022 | $12.5M | $152.9M | $5.4M |
| FY2023 | $12.2M | $97.6M | $4.1M |
| FY2024 | $10.3M | $45.8M | $3.9M |
| FY2025 | $7.5M | $94.0M | $3.5M |